ERBB2 and breast carcinoma: The infiltration of CTLs into the tumor microenvironment is mostly associated with a favorable prognosis in various types of solid malignancies including breast cancer, particularly the HER2-positive and triple-negative (TNBC) subtypes [16, 18].